arginine has been researched along with mesna in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boraso, A; Cargnoni, A; Comini, L; De Giuli, F; Ferrari, R; Scotti, C | 1 |
| Berti, T; D'Ancona, S; Magnolfi Zipoli, G | 1 |
| Boyd, JM; Clark, DD; Ensign, SA | 1 |
| Dombernowsky, P; Hansen, HH; Hirsch, FR; Ingeberg, S; Jeppesen, N; Kristensen, C; Osterlind, K; Sorensen, PG | 1 |
1 review(s) available for arginine and mesna
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and mesna
| Article | Year |
|---|---|
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesna; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2001 |
4 other study(ies) available for arginine and mesna
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effects of L-arginine mono(2-mercaptoethanesulfonate) on the ischemic and reperfused heart.
Topics: Adenosine Triphosphate; Animals; Arginine; Creatine Kinase; Free Radicals; Glutathione; Lactates; Lactic Acid; Mesna; Mitochondria, Heart; Myocardial Reperfusion Injury; Oxygen Consumption; Phosphocreatine; Rabbits; Sulfhydryl Compounds | 1992 |
Arginine 2-mercaptoethane sulfonate and sodium 2-mercaptoethane sulfonate: a comparative study of their effects upon tumour cells.
Topics: Animals; Antineoplastic Agents; Arginine; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Male; Melanoma, Experimental; Mercaptoethanol; Mesna; Mice; Tumor Cells, Cultured | 1988 |
The stereoselectivity and catalytic properties of Xanthobacter autotrophicus 2-[(R)-2-Hydroxypropylthio]ethanesulfonate dehydrogenase are controlled by interactions between C-terminal arginine residues and the sulfonate of coenzyme M.
Topics: Alcohol Oxidoreductases; Alcohols; Alkanesulfonates; Arginine; Binding Sites; Butanones; Catalysis; Catalytic Domain; Kinetics; Mesna; Mutagenesis, Site-Directed; Oxidation-Reduction; Stereoisomerism; Substrate Specificity; Xanthobacter | 2004 |